Solid Biosciences
SLDB
SLDB
69 hedge funds and large institutions have $332M invested in Solid Biosciences in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
4% less call options, than puts
Call options by funds: $5.44M | Put options by funds: $5.69M
7% less funds holding
Funds holding: 74 → 69 (-5)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Holders
69
Holding in Top 10
4
Calls
$5.44M
Puts
$5.69M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$26M | |
| 3 | +$19.5M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$19.5M |
| 5 |
AG
Artal Group
Luxembourg
|
+$5.17M |
Top Sellers
| 1 | -$3.23M | |
| 2 | -$1.73M | |
| 3 | -$1.63M | |
| 4 |
Renaissance Technologies
New York
|
-$1.22M |
| 5 |
PP
PDT Partners
New York
|
-$542K |